Results 41 to 50 of about 575,729 (357)

Mapping of succinate dehydrogenase losses in 2258 epithelial neoplasms. [PDF]

open access: yes, 2014
Losses in the succinate dehydrogenase (SDH) complex characterize 20% to 30% of extra-adrenal paragangliomas and 7% to 8% of gastric GISTs, and rare renal cell carcinomas.
Biernat, Wojciech   +9 more
core   +1 more source

Renal cell carcinoma

open access: yesBMJ, 2014
The treatment of renal cell carcinoma (RCC) has changed greatly over the past 15 years. Progress in the surgical management of the primary tumor and increased understanding of the molecular biology and genomics of the disease have led to the development of new therapeutic agents.
Jonasch, Eric   +2 more
openaire   +3 more sources

Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery [PDF]

open access: yes, 2014
BACKGROUND: Wider clinical applications of 9p status in clear cell renal cell carcinoma (ccRCC) are limited owing to the lack of validation and consensus for interphase fluorescent in situ hybridisation (I-FISH) scoring technique.
Bondad, J.   +7 more
core   +4 more sources

Limited utility of qPCR-based detection of tumor-specific circulating mRNAs in whole blood from clear cell renal cell carcinoma patients [PDF]

open access: yes, 2020
BACKGROUND: RNA sequencing data is providing abundant information about the levels of dysregulation of genes in various tumors. These data, as well as data based on older microarray technologies have enabled the identification of many genes which are ...
Busch, Jonas   +6 more
core   +2 more sources

The ambitious role of anti angiogenesis molecules: Turning a cold tumor into a hot one [PDF]

open access: yes, 2018
In renal cancer emerging treatment options are becoming available and there is a strong need to combine therapies to reformulate and adjourn clinical practice.
Botticelli, A.   +4 more
core   +1 more source

Prognostic significance of CKAP2L expression in patients with clear cell renal cell carcinoma

open access: yesFrontiers in Genetics, 2023
Background: Cytoskeleton-associated protein 2-like protein (CKAP2L) is thought to promote the progression of glioma, breast cancer, and ovarian cancer. However, the role of cytoskeleton-associated protein 2-like protein in clear cell renal cell carcinoma
Zhi Liu   +6 more
doaj   +1 more source

Metastatic renal cell carcinoma presenting as a paranasal sinus mass: the importance of differential diagnosis [PDF]

open access: yes, 2017
Metastases in the paranasal sinuses are rare; renal cell carcinoma is the most common cancer that metastasizes to this region. We present the case of a patient with a 4-month history of a rapidly growing mass of the nasal pyramid following a nasal trauma,
ALTISSIMI, Giancarlo   +3 more
core   +4 more sources

Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma. [PDF]

open access: yes, 2018
Extensive genome-wide analyses of deregulated gene expression have now been performed for many types of cancer. However, most studies have focused on deregulation at the gene-level, which may overlook the alterations of specific transcripts for a given ...
Girke, Thomas   +2 more
core   +1 more source

Accuracy of magnetic resonance imaging to identify pseudocapsule invasion in renal tumors [PDF]

open access: yes, 2020
Purpose: To evaluate accuracy of MRI in detecting renal tumor pseudocapsule (PC) invasion and to propose a classification based on imaging of PC status in patients with renal cell carcinoma.
Altobelli, Emanuela   +15 more
core   +1 more source

Surgical management for upper tract transitional cell carcinoma [PDF]

open access: yes, 2008
This review is published as a Cochrane Review in the Cochrane Database of Systematic Reviews 2008, Issue 4. Cochrane Reviews are regularly updated as new evidence emerges and in response to comments and criticisms, and the Cochrane Database of Systematic
Cohen, Nicholas P.   +5 more
core   +3 more sources

Home - About - Disclaimer - Privacy